Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of sustained-release oxycodone/paracetamol after orthopedic surgery
ChiCTR2400080139Phase 3Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of oxycodone + acetaminophen in acute postoperative pain (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Time-weighted sum of pain intensity difference from baseline within 48 hours after first dose. Started Jan 2024; status: recruiting.
02
Drugs
oxycodone + acetaminophen
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on ChiCTR2400080139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080139.